We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderate to severe UC (including associated symptoms such as joint pain, perianal fistula, diarrhea, frequent fevers and/or anemia), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce abdominal pain or cramping, kidney stones, constant need to poop, malnutrition, and/or eye pain associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children to join a clinical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or Inflammatory bowel disease (including associated symptoms such as tiredness, fatigue, diarrhea, malnutrition and/or joint pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing CD flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce tiredness, fever, abdominal pain, malnutrition, and/or eye pain associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for 2–17 years of age to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s and ulcerative colitis (including associated symptoms such as recurrent diarrhea, reduced appetite, bloody stool, weight loss and/or canker sores), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce diarrhea with blood, weight loss, constant need to poop, chronic fatigue, and/or canker sores associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2–17 years old to join a CD research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderate to severe IBD (including associated symptoms such as weight loss, perianal fistula, rectal pain, malnutrition and/or joint pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing CD flare-ups? Local clinical research is testing a potential new medication to see if it may reduce long-term diarrhea, perianal fistula, constant need to poop, weight loss, and/or liver disease associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for child to join a clinical trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderately to severely active IBD (including associated symptoms such as chronic diarrhea, diarrhea, bloody stool, weight loss and/or canker sores), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing CD flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce fever, unexplained weight loss, abdominal pain, malnutrition, and/or canker sores associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.